Across all groups, we observed increasing frequency of the APOE e4 allele in an ordered fashion, with the highest risk in AD (30.8%) followed by L-aMCI (24.0%), E-aMCI (15.1%), SMI (11.7%), and control (9.1%) groups (Table 2). The gene discussed is APOE; the disease is Alzheimer disease.